nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—UGT2B15—gall bladder—colon cancer	0.0445	0.274	CbGeAlD
Lorazepam—Unsteadiness—Fluorouracil—colon cancer	0.0351	0.0435	CcSEcCtD
Lorazepam—Pulmonary haemorrhage—Vincristine—colon cancer	0.0333	0.0413	CcSEcCtD
Lorazepam—Chlorthalidone—CA7—colon cancer	0.0209	0.689	CrCbGaD
Lorazepam—UGT2B15—digestive system—colon cancer	0.0175	0.108	CbGeAlD
Lorazepam—TSPO—blood vessel—colon cancer	0.0169	0.104	CbGeAlD
Lorazepam—Obstructive airways disorder—Methotrexate—colon cancer	0.0162	0.02	CcSEcCtD
Lorazepam—Application site pain—Fluorouracil—colon cancer	0.016	0.0199	CcSEcCtD
Lorazepam—Slurred speech—Fluorouracil—colon cancer	0.0158	0.0195	CcSEcCtD
Lorazepam—UGT2B15—liver—colon cancer	0.0131	0.0804	CbGeAlD
Lorazepam—Inappropriate antidiuretic hormone secretion—Vincristine—colon cancer	0.013	0.0161	CcSEcCtD
Lorazepam—Balance disorder—Fluorouracil—colon cancer	0.0129	0.016	CcSEcCtD
Lorazepam—Myoclonus—Vincristine—colon cancer	0.0126	0.0156	CcSEcCtD
Lorazepam—Pericardial effusion—Capecitabine—colon cancer	0.012	0.0149	CcSEcCtD
Lorazepam—Gastrointestinal symptom NOS—Fluorouracil—colon cancer	0.012	0.0149	CcSEcCtD
Lorazepam—Paralysis—Vincristine—colon cancer	0.0109	0.0135	CcSEcCtD
Lorazepam—TSPO—embryo—colon cancer	0.0101	0.0622	CbGeAlD
Lorazepam—Pneumothorax—Capecitabine—colon cancer	0.0099	0.0123	CcSEcCtD
Lorazepam—Balance disorder—Capecitabine—colon cancer	0.00901	0.0112	CcSEcCtD
Lorazepam—Pericardial effusion—Methotrexate—colon cancer	0.00894	0.0111	CcSEcCtD
Lorazepam—TSPO—epithelium—colon cancer	0.00825	0.0508	CbGeAlD
Lorazepam—Myoclonus—Capecitabine—colon cancer	0.00819	0.0101	CcSEcCtD
Lorazepam—TSPO—smooth muscle tissue—colon cancer	0.00795	0.0489	CbGeAlD
Lorazepam—Dysarthria—Irinotecan—colon cancer	0.00778	0.00964	CcSEcCtD
Lorazepam—Respiratory failure—Vincristine—colon cancer	0.0077	0.00954	CcSEcCtD
Lorazepam—TSPO—renal system—colon cancer	0.00765	0.0471	CbGeAlD
Lorazepam—Leukocytosis—Fluorouracil—colon cancer	0.0075	0.0093	CcSEcCtD
Lorazepam—Dysarthria—Fluorouracil—colon cancer	0.00745	0.00924	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Irinotecan—colon cancer	0.00736	0.00912	CcSEcCtD
Lorazepam—Salivary hypersecretion—Irinotecan—colon cancer	0.00715	0.00886	CcSEcCtD
Lorazepam—Coma—Vincristine—colon cancer	0.00691	0.00856	CcSEcCtD
Lorazepam—Coma—Fluorouracil—colon cancer	0.00644	0.00798	CcSEcCtD
Lorazepam—TSPO—lymphoid tissue—colon cancer	0.00635	0.0391	CbGeAlD
Lorazepam—Coagulopathy—Capecitabine—colon cancer	0.00633	0.00784	CcSEcCtD
Lorazepam—Memory impairment—Capecitabine—colon cancer	0.00628	0.00778	CcSEcCtD
Lorazepam—TSPO—digestive system—colon cancer	0.00628	0.0386	CbGeAlD
Lorazepam—Blood alkaline phosphatase increased—Irinotecan—colon cancer	0.00614	0.00761	CcSEcCtD
Lorazepam—Euphoric mood—Fluorouracil—colon cancer	0.00606	0.00751	CcSEcCtD
Lorazepam—Injection site pain—Capecitabine—colon cancer	0.00604	0.00748	CcSEcCtD
Lorazepam—TSPO—bone marrow—colon cancer	0.00578	0.0356	CbGeAlD
Lorazepam—Hypoxia—Methotrexate—colon cancer	0.00577	0.00715	CcSEcCtD
Lorazepam—Disorientation—Fluorouracil—colon cancer	0.00572	0.00709	CcSEcCtD
Lorazepam—Visual disturbance—Irinotecan—colon cancer	0.00564	0.00699	CcSEcCtD
Lorazepam—TSPO—vagina—colon cancer	0.00554	0.0341	CbGeAlD
Lorazepam—Hyponatraemia—Vincristine—colon cancer	0.00551	0.00683	CcSEcCtD
Lorazepam—Amnesia—Fluorouracil—colon cancer	0.00545	0.00675	CcSEcCtD
Lorazepam—Hyponatraemia—Irinotecan—colon cancer	0.00537	0.00665	CcSEcCtD
Lorazepam—Osteoarthritis—Irinotecan—colon cancer	0.00534	0.00662	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Irinotecan—colon cancer	0.00534	0.00662	CcSEcCtD
Lorazepam—Paralysis—Methotrexate—colon cancer	0.00528	0.00654	CcSEcCtD
Lorazepam—Lethargy—Fluorouracil—colon cancer	0.00522	0.00647	CcSEcCtD
Lorazepam—Cardiac arrest—Vincristine—colon cancer	0.00522	0.00646	CcSEcCtD
Lorazepam—Dysarthria—Capecitabine—colon cancer	0.00521	0.00645	CcSEcCtD
Lorazepam—Ataxia—Vincristine—colon cancer	0.00516	0.00639	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Fluorouracil—colon cancer	0.00512	0.00634	CcSEcCtD
Lorazepam—Osteoarthritis—Fluorouracil—colon cancer	0.00512	0.00634	CcSEcCtD
Lorazepam—Cardiac arrest—Irinotecan—colon cancer	0.00508	0.0063	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Capecitabine—colon cancer	0.00493	0.0061	CcSEcCtD
Lorazepam—Stupor—Methotrexate—colon cancer	0.00491	0.00609	CcSEcCtD
Lorazepam—Injection site reaction—Capecitabine—colon cancer	0.0049	0.00607	CcSEcCtD
Lorazepam—Irritability—Fluorouracil—colon cancer	0.00489	0.00605	CcSEcCtD
Lorazepam—Cardiac arrest—Fluorouracil—colon cancer	0.00487	0.00603	CcSEcCtD
Lorazepam—Ataxia—Fluorouracil—colon cancer	0.00481	0.00596	CcSEcCtD
Lorazepam—Urinary incontinence—Capecitabine—colon cancer	0.00476	0.00589	CcSEcCtD
Lorazepam—Depressed level of consciousness—Capecitabine—colon cancer	0.00476	0.00589	CcSEcCtD
Lorazepam—TSPO—liver—colon cancer	0.00468	0.0288	CbGeAlD
Lorazepam—Pancytopenia—Vincristine—colon cancer	0.0045	0.00558	CcSEcCtD
Lorazepam—Erectile dysfunction—Vincristine—colon cancer	0.00437	0.00541	CcSEcCtD
Lorazepam—Apnoea—Methotrexate—colon cancer	0.00433	0.00536	CcSEcCtD
Lorazepam—Mental disability—Capecitabine—colon cancer	0.00428	0.0053	CcSEcCtD
Lorazepam—GABRB3—liver—colon cancer	0.00424	0.0261	CbGeAlD
Lorazepam—Pancytopenia—Fluorouracil—colon cancer	0.0042	0.0052	CcSEcCtD
Lorazepam—Sleep disorder—Capecitabine—colon cancer	0.00413	0.00512	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Capecitabine—colon cancer	0.00411	0.00509	CcSEcCtD
Lorazepam—Jaundice—Irinotecan—colon cancer	0.00401	0.00497	CcSEcCtD
Lorazepam—Dysarthria—Methotrexate—colon cancer	0.00388	0.0048	CcSEcCtD
Lorazepam—Amnesia—Capecitabine—colon cancer	0.00381	0.00472	CcSEcCtD
Lorazepam—Hallucination—Vincristine—colon cancer	0.00378	0.00468	CcSEcCtD
Lorazepam—Bradycardia—Irinotecan—colon cancer	0.00376	0.00466	CcSEcCtD
Lorazepam—Respiratory failure—Methotrexate—colon cancer	0.00374	0.00463	CcSEcCtD
Lorazepam—Agranulocytosis—Fluorouracil—colon cancer	0.00368	0.00456	CcSEcCtD
Lorazepam—Lethargy—Capecitabine—colon cancer	0.00365	0.00452	CcSEcCtD
Lorazepam—Hyponatraemia—Capecitabine—colon cancer	0.00359	0.00445	CcSEcCtD
Lorazepam—TSPO—lymph node—colon cancer	0.00358	0.0221	CbGeAlD
Lorazepam—Cystitis noninfective—Methotrexate—colon cancer	0.00358	0.00444	CcSEcCtD
Lorazepam—Diplopia—Capecitabine—colon cancer	0.00358	0.00443	CcSEcCtD
Lorazepam—Osteoarthritis—Capecitabine—colon cancer	0.00358	0.00443	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.00358	0.00443	CcSEcCtD
Lorazepam—Visual impairment—Irinotecan—colon cancer	0.00356	0.00441	CcSEcCtD
Lorazepam—Cystitis—Methotrexate—colon cancer	0.00354	0.00439	CcSEcCtD
Lorazepam—Depressed level of consciousness—Methotrexate—colon cancer	0.00354	0.00439	CcSEcCtD
Lorazepam—Irritability—Capecitabine—colon cancer	0.00341	0.00423	CcSEcCtD
Lorazepam—Cardiac arrest—Capecitabine—colon cancer	0.0034	0.00421	CcSEcCtD
Lorazepam—Ataxia—Capecitabine—colon cancer	0.00336	0.00417	CcSEcCtD
Lorazepam—Alopecia—Vincristine—colon cancer	0.00335	0.00416	CcSEcCtD
Lorazepam—Coma—Methotrexate—colon cancer	0.00335	0.00415	CcSEcCtD
Lorazepam—Chills—Irinotecan—colon cancer	0.00332	0.00411	CcSEcCtD
Lorazepam—Bladder pain—Methotrexate—colon cancer	0.00332	0.00411	CcSEcCtD
Lorazepam—Arrhythmia—Irinotecan—colon cancer	0.0033	0.00409	CcSEcCtD
Lorazepam—Liver function test abnormal—Capecitabine—colon cancer	0.0033	0.00409	CcSEcCtD
Lorazepam—Alopecia—Irinotecan—colon cancer	0.00327	0.00405	CcSEcCtD
Lorazepam—Pulmonary oedema—Methotrexate—colon cancer	0.00326	0.00405	CcSEcCtD
Lorazepam—Arrhythmia—Fluorouracil—colon cancer	0.00316	0.00392	CcSEcCtD
Lorazepam—Alopecia—Fluorouracil—colon cancer	0.00313	0.00388	CcSEcCtD
Lorazepam—Erythema—Fluorouracil—colon cancer	0.00308	0.00382	CcSEcCtD
Lorazepam—Agitation—Vincristine—colon cancer	0.00304	0.00376	CcSEcCtD
Lorazepam—Vertigo—Vincristine—colon cancer	0.00297	0.00368	CcSEcCtD
Lorazepam—Pancytopenia—Capecitabine—colon cancer	0.00294	0.00364	CcSEcCtD
Lorazepam—Vision blurred—Fluorouracil—colon cancer	0.00291	0.0036	CcSEcCtD
Lorazepam—Vertigo—Irinotecan—colon cancer	0.00289	0.00358	CcSEcCtD
Lorazepam—Convulsion—Vincristine—colon cancer	0.00286	0.00355	CcSEcCtD
Lorazepam—Hypertension—Vincristine—colon cancer	0.00285	0.00353	CcSEcCtD
Lorazepam—Visual disturbance—Methotrexate—colon cancer	0.00281	0.00348	CcSEcCtD
Lorazepam—Hypertension—Irinotecan—colon cancer	0.00278	0.00344	CcSEcCtD
Lorazepam—Lethargy—Methotrexate—colon cancer	0.00272	0.00337	CcSEcCtD
Lorazepam—Jaundice—Capecitabine—colon cancer	0.00269	0.00333	CcSEcCtD
Lorazepam—Infection—Vincristine—colon cancer	0.00268	0.00332	CcSEcCtD
Lorazepam—Convulsion—Fluorouracil—colon cancer	0.00267	0.00331	CcSEcCtD
Lorazepam—Osteoarthritis—Methotrexate—colon cancer	0.00266	0.0033	CcSEcCtD
Lorazepam—Confusional state—Irinotecan—colon cancer	0.00265	0.00328	CcSEcCtD
Lorazepam—Thrombocytopenia—Vincristine—colon cancer	0.00264	0.00327	CcSEcCtD
Lorazepam—Infection—Irinotecan—colon cancer	0.00261	0.00323	CcSEcCtD
Lorazepam—Agranulocytosis—Capecitabine—colon cancer	0.00257	0.00319	CcSEcCtD
Lorazepam—Thrombocytopenia—Irinotecan—colon cancer	0.00257	0.00319	CcSEcCtD
Lorazepam—Irritability—Methotrexate—colon cancer	0.00254	0.00315	CcSEcCtD
Lorazepam—Confusional state—Fluorouracil—colon cancer	0.00254	0.00314	CcSEcCtD
Lorazepam—Hypotension—Vincristine—colon cancer	0.00252	0.00312	CcSEcCtD
Lorazepam—Bradycardia—Capecitabine—colon cancer	0.00252	0.00312	CcSEcCtD
Lorazepam—Ataxia—Methotrexate—colon cancer	0.0025	0.0031	CcSEcCtD
Lorazepam—Infection—Fluorouracil—colon cancer	0.0025	0.0031	CcSEcCtD
Lorazepam—Thrombocytopenia—Fluorouracil—colon cancer	0.00246	0.00305	CcSEcCtD
Lorazepam—Liver function test abnormal—Methotrexate—colon cancer	0.00246	0.00305	CcSEcCtD
Lorazepam—Tachycardia—Fluorouracil—colon cancer	0.00246	0.00304	CcSEcCtD
Lorazepam—Hypotension—Irinotecan—colon cancer	0.00245	0.00304	CcSEcCtD
Lorazepam—Visual impairment—Capecitabine—colon cancer	0.00238	0.00295	CcSEcCtD
Lorazepam—Hypotension—Fluorouracil—colon cancer	0.00235	0.00291	CcSEcCtD
Lorazepam—Somnolence—Irinotecan—colon cancer	0.00234	0.00289	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Vincristine—colon cancer	0.00233	0.00288	CcSEcCtD
Lorazepam—Fatigue—Vincristine—colon cancer	0.00233	0.00288	CcSEcCtD
Lorazepam—Constipation—Vincristine—colon cancer	0.00231	0.00286	CcSEcCtD
Lorazepam—Pain—Vincristine—colon cancer	0.00231	0.00286	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Irinotecan—colon cancer	0.00227	0.00281	CcSEcCtD
Lorazepam—Fatigue—Irinotecan—colon cancer	0.00226	0.00281	CcSEcCtD
Lorazepam—Constipation—Irinotecan—colon cancer	0.00225	0.00278	CcSEcCtD
Lorazepam—Pain—Irinotecan—colon cancer	0.00225	0.00278	CcSEcCtD
Lorazepam—Somnolence—Fluorouracil—colon cancer	0.00224	0.00277	CcSEcCtD
Lorazepam—Chills—Capecitabine—colon cancer	0.00222	0.00275	CcSEcCtD
Lorazepam—Arrhythmia—Capecitabine—colon cancer	0.00221	0.00274	CcSEcCtD
Lorazepam—Alopecia—Capecitabine—colon cancer	0.00219	0.00271	CcSEcCtD
Lorazepam—Pancytopenia—Methotrexate—colon cancer	0.00219	0.00271	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00217	0.00269	CcSEcCtD
Lorazepam—Feeling abnormal—Irinotecan—colon cancer	0.00216	0.00268	CcSEcCtD
Lorazepam—Erythema—Capecitabine—colon cancer	0.00215	0.00267	CcSEcCtD
Lorazepam—Pain—Fluorouracil—colon cancer	0.00215	0.00267	CcSEcCtD
Lorazepam—Erectile dysfunction—Methotrexate—colon cancer	0.00212	0.00263	CcSEcCtD
Lorazepam—Feeling abnormal—Fluorouracil—colon cancer	0.00207	0.00257	CcSEcCtD
Lorazepam—Drowsiness—Methotrexate—colon cancer	0.00205	0.00254	CcSEcCtD
Lorazepam—Vision blurred—Capecitabine—colon cancer	0.00203	0.00252	CcSEcCtD
Lorazepam—Tremor—Capecitabine—colon cancer	0.00202	0.0025	CcSEcCtD
Lorazepam—Hypersensitivity—Vincristine—colon cancer	0.00199	0.00246	CcSEcCtD
Lorazepam—Vertigo—Capecitabine—colon cancer	0.00194	0.0024	CcSEcCtD
Lorazepam—Hypersensitivity—Irinotecan—colon cancer	0.00194	0.0024	CcSEcCtD
Lorazepam—Asthenia—Vincristine—colon cancer	0.00194	0.0024	CcSEcCtD
Lorazepam—Agranulocytosis—Methotrexate—colon cancer	0.00191	0.00237	CcSEcCtD
Lorazepam—Asthenia—Irinotecan—colon cancer	0.00188	0.00233	CcSEcCtD
Lorazepam—Hypertension—Capecitabine—colon cancer	0.00186	0.0023	CcSEcCtD
Lorazepam—Hypersensitivity—Fluorouracil—colon cancer	0.00185	0.0023	CcSEcCtD
Lorazepam—Diclofenac—PTGS2—colon cancer	0.00185	0.0609	CrCbGaD
Lorazepam—Dry mouth—Capecitabine—colon cancer	0.00179	0.00222	CcSEcCtD
Lorazepam—Dizziness—Vincristine—colon cancer	0.00178	0.00221	CcSEcCtD
Lorazepam—Visual impairment—Methotrexate—colon cancer	0.00178	0.0022	CcSEcCtD
Lorazepam—Confusional state—Capecitabine—colon cancer	0.00177	0.0022	CcSEcCtD
Lorazepam—Infection—Capecitabine—colon cancer	0.00175	0.00216	CcSEcCtD
Lorazepam—Dizziness—Irinotecan—colon cancer	0.00174	0.00215	CcSEcCtD
Lorazepam—Thrombocytopenia—Capecitabine—colon cancer	0.00172	0.00213	CcSEcCtD
Lorazepam—Tachycardia—Capecitabine—colon cancer	0.00172	0.00213	CcSEcCtD
Lorazepam—Vomiting—Vincristine—colon cancer	0.00171	0.00212	CcSEcCtD
Lorazepam—Rash—Vincristine—colon cancer	0.0017	0.00211	CcSEcCtD
Lorazepam—Dermatitis—Vincristine—colon cancer	0.0017	0.0021	CcSEcCtD
Lorazepam—Headache—Vincristine—colon cancer	0.00169	0.00209	CcSEcCtD
Lorazepam—Vomiting—Irinotecan—colon cancer	0.00167	0.00207	CcSEcCtD
Lorazepam—Dizziness—Fluorouracil—colon cancer	0.00166	0.00206	CcSEcCtD
Lorazepam—Rash—Irinotecan—colon cancer	0.00166	0.00205	CcSEcCtD
Lorazepam—Dermatitis—Irinotecan—colon cancer	0.00165	0.00205	CcSEcCtD
Lorazepam—Chills—Methotrexate—colon cancer	0.00165	0.00205	CcSEcCtD
Lorazepam—Headache—Irinotecan—colon cancer	0.00165	0.00204	CcSEcCtD
Lorazepam—Hypotension—Capecitabine—colon cancer	0.00164	0.00204	CcSEcCtD
Lorazepam—Alopecia—Methotrexate—colon cancer	0.00163	0.00202	CcSEcCtD
Lorazepam—Erythema—Methotrexate—colon cancer	0.0016	0.00199	CcSEcCtD
Lorazepam—Nausea—Vincristine—colon cancer	0.0016	0.00198	CcSEcCtD
Lorazepam—Vomiting—Fluorouracil—colon cancer	0.0016	0.00198	CcSEcCtD
Lorazepam—Rash—Fluorouracil—colon cancer	0.00159	0.00197	CcSEcCtD
Lorazepam—Dermatitis—Fluorouracil—colon cancer	0.00158	0.00196	CcSEcCtD
Lorazepam—Headache—Fluorouracil—colon cancer	0.00158	0.00195	CcSEcCtD
Lorazepam—Diclofenac—ABCB1—colon cancer	0.00157	0.0518	CrCbGaD
Lorazepam—Nausea—Irinotecan—colon cancer	0.00156	0.00193	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Capecitabine—colon cancer	0.00152	0.00188	CcSEcCtD
Lorazepam—Fatigue—Capecitabine—colon cancer	0.00152	0.00188	CcSEcCtD
Lorazepam—Vision blurred—Methotrexate—colon cancer	0.00151	0.00187	CcSEcCtD
Lorazepam—Pain—Capecitabine—colon cancer	0.0015	0.00186	CcSEcCtD
Lorazepam—Constipation—Capecitabine—colon cancer	0.0015	0.00186	CcSEcCtD
Lorazepam—Nausea—Fluorouracil—colon cancer	0.00149	0.00185	CcSEcCtD
Lorazepam—Feeling abnormal—Capecitabine—colon cancer	0.00145	0.00179	CcSEcCtD
Lorazepam—Vertigo—Methotrexate—colon cancer	0.00144	0.00178	CcSEcCtD
Lorazepam—Convulsion—Methotrexate—colon cancer	0.00139	0.00172	CcSEcCtD
Lorazepam—Confusional state—Methotrexate—colon cancer	0.00132	0.00163	CcSEcCtD
Lorazepam—Infection—Methotrexate—colon cancer	0.0013	0.00161	CcSEcCtD
Lorazepam—Hypersensitivity—Capecitabine—colon cancer	0.0013	0.0016	CcSEcCtD
Lorazepam—Thrombocytopenia—Methotrexate—colon cancer	0.00128	0.00159	CcSEcCtD
Lorazepam—Asthenia—Capecitabine—colon cancer	0.00126	0.00156	CcSEcCtD
Lorazepam—Hypotension—Methotrexate—colon cancer	0.00122	0.00152	CcSEcCtD
Lorazepam—Nitrazepam—ABCB1—colon cancer	0.00119	0.0392	CrCbGaD
Lorazepam—Somnolence—Methotrexate—colon cancer	0.00116	0.00144	CcSEcCtD
Lorazepam—Dizziness—Capecitabine—colon cancer	0.00116	0.00144	CcSEcCtD
Lorazepam—Chlorprothixene—ABCB1—colon cancer	0.00113	0.0373	CrCbGaD
Lorazepam—Gastrointestinal disorder—Methotrexate—colon cancer	0.00113	0.0014	CcSEcCtD
Lorazepam—Fatigue—Methotrexate—colon cancer	0.00113	0.0014	CcSEcCtD
Lorazepam—Pain—Methotrexate—colon cancer	0.00112	0.00139	CcSEcCtD
Lorazepam—Vomiting—Capecitabine—colon cancer	0.00112	0.00138	CcSEcCtD
Lorazepam—Rash—Capecitabine—colon cancer	0.00111	0.00137	CcSEcCtD
Lorazepam—Dermatitis—Capecitabine—colon cancer	0.00111	0.00137	CcSEcCtD
Lorazepam—Headache—Capecitabine—colon cancer	0.0011	0.00136	CcSEcCtD
Lorazepam—Feeling abnormal—Methotrexate—colon cancer	0.00108	0.00134	CcSEcCtD
Lorazepam—Flurazepam—ABCB1—colon cancer	0.00106	0.0348	CrCbGaD
Lorazepam—Nausea—Capecitabine—colon cancer	0.00104	0.00129	CcSEcCtD
Lorazepam—Midazolam—ABCB1—colon cancer	0.000981	0.0323	CrCbGaD
Lorazepam—Hypersensitivity—Methotrexate—colon cancer	0.000964	0.00119	CcSEcCtD
Lorazepam—Asthenia—Methotrexate—colon cancer	0.000939	0.00116	CcSEcCtD
Lorazepam—Dizziness—Methotrexate—colon cancer	0.000865	0.00107	CcSEcCtD
Lorazepam—Diazepam—ABCB1—colon cancer	0.00084	0.0277	CrCbGaD
Lorazepam—Vomiting—Methotrexate—colon cancer	0.000832	0.00103	CcSEcCtD
Lorazepam—Clozapine—ABCB1—colon cancer	0.00083	0.0273	CrCbGaD
Lorazepam—Rash—Methotrexate—colon cancer	0.000825	0.00102	CcSEcCtD
Lorazepam—Dermatitis—Methotrexate—colon cancer	0.000824	0.00102	CcSEcCtD
Lorazepam—Headache—Methotrexate—colon cancer	0.00082	0.00102	CcSEcCtD
Lorazepam—Nausea—Methotrexate—colon cancer	0.000777	0.000963	CcSEcCtD
